Single Nucleotide Polymorphism Discovery in TBX1 in Individuals with and without 22q11.2 Deletion Syndrome

被引:6
|
作者
Heike, Carrie L. [1 ,2 ]
Starr, Jacqueline R. [1 ,2 ]
Rieder, Mark J. [3 ]
Cunningham, Michael L. [1 ,2 ]
Edwards, Karen L. [4 ]
Stanaway, Ian B. [3 ]
Crawford, Dana C. [5 ]
机构
[1] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98105 USA
[2] Seattle Childrens Hosp, Seattle, WA 98105 USA
[3] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA
[4] Univ Washington, Dept Epidemiol, Inst Publ Hlth Genet, Seattle, WA 98105 USA
[5] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
22q11.2 deletion syndrome; TBX1; single nucleotide polymorphism discovery; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR DEFECTS; LINKAGE DISEQUILIBRIUM; HEART-DEFECTS; INNER-EAR; GENE; POPULATION; PHENOTYPE; SNPS; MALFORMATIONS;
D O I
10.1002/bdra.20604
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Children with 22q11.2 deletion syndrome (22q11.2DS) have a wide range of clinical features. TBX1 has been proposed as a candidate gene for some of the features in this condition. Polymorphisms in the nondeleted TBX1, which may affect the function of the sole TBX1 gene in individuals with the 22q11.2DS, may be a key to understanding the phenotypic variability among individuals with a shared deletion. Comprehensive single nucleotide polymorphism (SNP) discovery by resequencing candidate genes can identify genetic variants that influence a given phenotype. The purpose of this study was to further characterize the sequence variability in TBX1 by identifying all common SNPs in this gene. METHODS: We resequenced TBX1 in 29 children with a documented 22q11.2 deletion and 95 nondeleted, healthy individuals. We estimated allele frequencies, performed tagSNP selection, and inferred haplotypes. We also compared SNP frequencies between 22q11.2DS and control samples. RESULTS: We identified 355 biallelic markers among the 190 chromosomes resequenced in the control panel. The vast majority of the markers identified were SNPs (n = 331), and the remainder indels (n = 24). We did not identify SNPs or indels in the cis- regulatory element (FOX-binding site) upstream of TBX1. In children with 22q11.2DS we detected 187 biallelic markers, six of which were indels. Four of the seven coding SNPs identified in the controls were identified in children with 22q11.2DS. CONCLUSIONS: This comprehensive SNP discovery data can be used to select SNPs to genotype for future association studies assessing the role of TBX1 and phenotypic variability in individuals with 22q11.2DS. Birth Defects Research (Part A) 88:54-63, 2010. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:54 / 63
页数:10
相关论文
共 50 条
  • [41] Differences in speech and language abilities between children with 22q11.2 deletion syndrome and children with phenotypic features of 22q11.2 deletion syndrome but without microdeletion
    Rakonjac, Marijana
    Cuturilo, Goran
    Stevanovic, Milena
    Jelicic, Ljiljana
    Subotic, Misko
    Jovanovic, Ida
    Drakulic, Danijela
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2016, 55 : 322 - 329
  • [42] Genotype and Cardiovascular Phenotype Correlations with TBX1 in 1,022 Velo-Cardio-Facial/DiGeorge/22q11.2 Deletion Syndrome Patients
    Guo, Tingwei
    McDonald-McGinn, Donna
    Blonska, Anna
    Shanske, Alan
    Bassett, Anne S.
    Chow, Eva
    Bowser, Mark
    Sheridan, Molly
    Beemer, Frits
    Devriendt, Koen
    Swillen, Ann
    Breckpot, Jeroen
    Digilio, Maria C.
    Marino, Bruno
    Dallapiccola, Bruno
    Carpenter, Courtney
    Zheng, Xin
    Johnson, Jacob
    Chung, Jonathan
    Higgins, Anne Marie
    Philip, Nicole
    Simon, Tony J.
    Coleman, Karlene
    Heine-Suner, Damian
    Rosell, Jordi
    Kates, Wendy
    Devoto, Marcella
    Goldmuntz, Elizabeth
    Zackai, Elaine
    Wang, Tao
    Shprintzen, Robert
    Emanuel, Beverly
    Morrow, Bernice
    HUMAN MUTATION, 2011, 32 (11) : 1278 - 1289
  • [43] 22q11 deletion syndrome and the role of the TBX1 transcription
    Scambler, PJ
    Ivins, S
    Ataliotis, P
    Prescott, K
    Latinkic, B
    Mohun, T
    Lindsay, E
    Pramparo, T
    Baldini, A
    JOURNAL OF MEDICAL GENETICS, 2002, 39 : S20 - S20
  • [44] Mapping the deletion endpoints in individuals with 22q11.2 Deletion Syndrome by droplet digital PCR
    Hwang, Vicki J.
    Maar, Dianna
    Regan, John
    Angkustsiri, Kathleen
    Simon, Tony J.
    Tassone, Flora
    BMC MEDICAL GENETICS, 2014, 15
  • [45] Clozapine Use in 22q11.2 Deletion Syndrome
    Colijn, Mark Ainsley
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 168 - 178
  • [46] Tonsillectomy in Children with 22q11.2 Deletion Syndrome
    Arganbright, Jill M.
    Hankey, Paul Bryan
    Tracy, Meghan
    Narayanan, Srivats
    Noel-MacDonnell, Janelle
    Ingram, David
    GENES, 2022, 13 (12)
  • [47] Otolaryngologic manifestations of the 22q11.2 deletion syndrome
    Dyce, O
    McDonald-McGinn, D
    Kirschner, RE
    Zackai, E
    Young, K
    Jacobs, IN
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (12) : 1408 - 1412
  • [48] 22q11.2 deletion syndrome: an anaesthetic perspective
    Kemp, N.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2021, 27 (05) : 206 - 210
  • [49] Labyrinthine malformation in the 22q11.2 deletion syndrome
    Hopsu, Erkki
    Markkola, Antti
    Pitkaranta, Anne
    CLINICAL DYSMORPHOLOGY, 2007, 16 (01) : 67 - 68
  • [50] Developmental trajectories in 22q11.2 deletion syndrome
    Swillen, Ann
    McDonald-McGinn, Donna
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2015, 169 (02) : 172 - 181